Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation

One of the major breakthroughs to combat the current Coronavirus Disease 2019 (COVID-19) pandemic has been the development of highly effective vaccines against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Still, alternatives are needed for individuals who are at high risk of dev...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Straten, Karlijn, van Gils, Marit J., de Taeye, Steven W., de Bree, Godelieve J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996231/
https://www.ncbi.nlm.nih.gov/pubmed/35419561
http://dx.doi.org/10.3389/fmedt.2022.867982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996231/
https://www.ncbi.nlm.nih.gov/pubmed/35419561
http://dx.doi.org/10.3389/fmedt.2022.867982

Ejemplares similares